Jackson Jennifer L, Judd Suzanne E, Panwar Bhupesh, Howard Virginia J, Wadley Virginia G, Jenny Nancy S, Gutiérrez Orlando M
Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.
Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL.
J Clin Transl Endocrinol. 2016 Sep;5:21-25. doi: 10.1016/j.jcte.2016.06.002.
Vitamin D is a fat-soluble vitamin classically known for its role in calcium absorption and bone health. Growing evidence indicates that vitamin D deficiency may be associated with inflammation, insulin resistance, and obesity. However, prior studies examining the association of vitamin D with metabolic risk factors had relatively low representation of individuals of black race, limiting their ability to characterize associations of vitamin D and parameters of metabolic health in black vs. white individuals.
We examined associations of 25-hydroxyvitamin D (25(OH)D) concentrations with markers of inflammation (interleukin [IL]-6, IL-10, high sensitivity C-reactive protein [hsCRP]), insulin sensitivity (adiponectin, resistin, HOMA-IR), and obesity (body mass index [BMI], waist circumference) in 1,042 participants from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, a large national cohort of black and white adults 45 years or older.
In unadjusted analyses, lower 25(OH)D concentrations were associated with higher IL-6 and hsCRP concentrations; lower adiponectin concentrations; higher HOMA-IR; and higher BMI and waist circumference (<0.05 for all). After adjustment for sociodemographic, clinical, lifestyle, and laboratory variables, lower 25(OH) D concentrations remained associated with lower adiponectin concentrations, higher IL-6 concentrations, higher HOMA-IR, and higher BMI and waist circumference ( <0.05 for all). The magnitude of these associations did not differ by race (>0.1).
Lower 25(OH)D concentrations are associated with disturbances in metabolic health in both blacks and whites. Whether correcting vitamin D deficiency could offer a beneficial therapy for additional disease prevention requires further study.
维生素D是一种脂溶性维生素,传统上因其在钙吸收和骨骼健康方面的作用而闻名。越来越多的证据表明,维生素D缺乏可能与炎症、胰岛素抵抗和肥胖有关。然而,先前研究维生素D与代谢风险因素之间的关联时,黑人个体的代表性相对较低,限制了其描述黑人和白人个体中维生素D与代谢健康参数之间关联的能力。
我们在来自“中风地理和种族差异原因”(REGARDS)研究的1042名参与者中,研究了25-羟基维生素D(25(OH)D)浓度与炎症标志物(白细胞介素[IL]-6、IL-10、高敏C反应蛋白[hsCRP])、胰岛素敏感性(脂联素、抵抗素、稳态模型评估胰岛素抵抗指数[HOMA-IR])和肥胖(体重指数[BMI]、腰围)之间的关联。REGARDS研究是一个由45岁及以上黑人和白人成年人组成的大型全国性队列。
在未调整的分析中,较低的25(OH)D浓度与较高的IL-6和hsCRP浓度、较低的脂联素浓度、较高的HOMA-IR以及较高的BMI和腰围相关(所有P<0.05)。在调整了社会人口统计学、临床、生活方式和实验室变量后,较低的25(OH)D浓度仍与较低的脂联素浓度、较高的IL-6浓度、较高的HOMA-IR以及较高的BMI和腰围相关(所有P<0.05)。这些关联的程度在种族之间没有差异(P>0.1)。
较低的25(OH)D浓度与黑人和白人的代谢健康紊乱有关。纠正维生素D缺乏是否能为预防其他疾病提供有益的治疗方法,还需要进一步研究。